Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

BACKGROUND: Recent circumstantial evidence suggests that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime), the first line of treatment in Iran. This study was designed to determine whether the clinical responses (healing, or...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hadighi, Ramtin, Mohebali, Mehdi, Boucher, Patrick, Hajjaran, Homa, Khamesipour, Ali, Ouellette, Marc
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2006
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1435779/
https://ncbi.nlm.nih.gov/pubmed/16605301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.0030162
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars